AcupunctureNCT04931355
Acupuncture in the Freeze-all IVF Cycle
A study testing Acupuncture and Western medicine in people with Acupuncture and Female Infertility, run by Peking University Third Hospital at 1 site in China.
Trial summary
In the early stage, our team found that Acupuncture intervention in freeze-all IVF cycles can improve the clinical pregnancy rate. In order to further study the role of Acupuncture in improving the pregnancy outcome of IVF-ET in infertility. A randomized controlled clinical trial will be used in this study. Read more about this study
- Who is it for?
- Ages 20 to 40 years, women only
- Conditions the study is for
- Acupuncture, Female Infertility
- What is being tested?
- Acupuncture and Western medicine
- Type of treatment
- Pill or oral medicine, Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 siteChina
- Study dates
- 1 Jun 2023to 30 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Meet the diagnostic criteria for infertility.
- Meet the criteria for identifying kidney deficiency in TCM.
- Patients who Planning to undergo IVF-ET for pregnancy in our center, Age ≤40 years and ≥25 years.
- Previous embryo transfer failure ≥ 2 times.
- Menstrual cycle is basically normal, and normal ovulation has been monitored in the past.
- There were more than 1 blastocyst /more than 2 high-quality embryos with more than 6 cells on day 3/more than 2 high-quality embryos with more than 4 cells on day 2.
- Consent to participate in this clinical trial and sign an informed consent form.
Who cannot join
- Patients with endometritis, acute pelvic inflammatory disease, mycotic vaginitis, bacterial vaginitis, adnexitis or other systemic infections.
- It has been confirmed that there are obvious and serious other organic lesions in the reproductive organs.
- Patients with allergic constitution
- Infertility caused by genetic factors
- Patients with serious primary diseases such as cardio cerebrovascular, kidney, liver and hematopoietic system and psychosis
- A person who is unable to cooperate (such as a combination of neurological or mental illness, or a reluctance to cooperate)
- The endometrial thickness on the day of hCG was less than 6 mm or the endometrial morphology on the day of hCG was type C
- Those who did not agree to participate in the study
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Peking University Third Hospital
Beijing, China, 100029
xiyan C xin
About this study
Official title: A Randomized Controlled Study on the Short-term Intervention of Acupuncture in the Freeze-all IVF Cycle to Improve Pregnancy Rate
In the early stage, our team found that Acupuncture intervention in freeze-all IVF cycles can improve the clinical pregnancy rate. In order to further study the role of Acupuncture in improving the pregnancy outcome of IVF-ET in infertility. A randomized controlled clinical trial will be used in this study. 90 infertile patients are randomly divided into two groups. The control group will be treated with conventional modern medicine, and the treatment group will be treated with Acupuncture on the basis of conventional modern medicine. The intervention starts from the 5th day of the menstrual cycle and lasts to the day before IVF-ET. The number of oocytes, antral follicles, AMH, serum FSH, and clinical pregnancy rate will be observed to evaluate the effect of Acupuncture on the improvement of pregnancy outcome. In addition, all of the participants will be asked to complete the self-evaluation of the anxiety/depression scale on the 7th day of the menstrual cycle, before and after transplantation, to analyze the emotional changes of the subjects during the study. We observe the safety and health economic indicators of Acupuncture treatment, so as to improve the overall efficacy of TCM Combined Application in assisted reproductive technology in the future.
Read the detailed description
The study will be conducted on patients with DOR attending our reproductive medicine center for proposed IVF-ET between June 2021and December 2022.
The trial is designed as a randomized, controlled clinical trial with two groups established by 1:1 equal allocation, a treatment group with interventions using acupuncture to tonify the kidneys and regulate blood and a control group treated using conventional Western medicine.
Random numbers will be prepared by an independent third-party statistician who prepared a list of random group codes for this study. Enrolled subjects will be given a subject number during the screening process and, upon formal enrolment, will be randomly assigned to either the test or control group with a corresponding random number.
The acupoints used will be:
Zhongwan (RN12) ：The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Qihai(RN6): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Guanyuan(RN4): The needle should be punctured for 0.8-1.2 inches and retained for 30 minutes.
Zhongji(RN3): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes.
Guilai(ST29): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes.
Shenshu(BL23): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes.
Ciliao(BL28): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Xuehai(SP10): The needle should be punctured for 1-1.5 inches and retained for 30 minutes.
Zusanli(ST36): The needle should be punctured for 1-1.5 inches and retained for 30 minutes.
Diji(SP8): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Sanyinjiao(SP6): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Taixi(KI6): The needle should be punctured for 0.8-1.2 inches and retained for 30 minutes.
Baihui(DU20): The needle should be punctured for 0.5-1.0 inches and retained for 30 minutes.
Yintang(EX-HN3): The needle should be punctured for 0.5-1.0 inches and retained for 30 minutes.
The Acupuncture intervention will start on the 5th day of the menstruation cycle, which will be carried out 1 time per day,at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention.
Serum human chorionic gonadotropin (hCG) will be measured, and an hCG>30 IU will be considered to indicate biochemical pregnancy. Ultrasound monitoring will be performed 30 days after ET to calculate the clinical pregnancy rate.
- Conditions
- Acupuncture, Female Infertility
- Being tested
- Acupuncture, Western medicine
- Keywords
- Acupuncture, Traditional chinese medicine, freeze-all IVF cycle, Embryo Transfer
- Medical subject headings
- Infertility, Female
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AcupunctureOther
Also called conventional western medicine(Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection )
The Acupuncture intervention（Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi.） will start on the 5th day of menstruation cycle, which will be carried out 1 time per day, at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention.
Western medicineOther
Western medicine
| Study group | Role | What they receive |
|---|---|---|
| Acupuncture treatment group | Experimental | Method: Acupuncture at Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi. The acupuncture treatment starts on the 5th day of the menstrual cycle and lasts to the days before IVF-ET Receives: Other: Acupuncture |
| Western medicine group | Active comparator | The western medicine group will be treated with conventional western medicine Receives: Other: Western medicine |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical pregnancy rate (%)
Follow up by telephone calls 14days after the IVF-ET
Measured: up to 6 weeks from enrollment
Secondary outcomes (1)
Concentration of β-human Choriogonadotropin(β-HCG)
Obtained by blood sampling 14 days after the proposed IVF-ET
Measured: up to 6 weeks from enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jun 2021
- Study start1 Jun 2023 (estimated)
- Primary completion30 Dec 2024 (estimated)
- Study completion30 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AcupunctureStudies of the same condition, open and under way.
- More trials run by Peking University Third HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Peking University Third Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04931355
- Sponsor's protocol ID
- IRB00006761-M2020443
- Status last verified
- Jan 2023
- First submitted
- 15 Jun 2021
- Last updated
- 31 May 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Study on the Short-term Intervention of Acupuncture in the Freeze-all IVF Cycle to Improve Pregnancy Rate
- ClinicalTrials.gov ID
- NCT04931355
- Acronym / sponsor ID
- IRB00006761-M2020443
- Conditions
- Acupuncture, Female Infertility
- Keywords
- Acupuncture, Traditional chinese medicine, freeze-all IVF cycle, Embryo Transfer
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Peking University Third HospitalUniversity, hospital or other
- Study start
- 1 Jun 2023 (estimated)
- Primary completion
- 30 Dec 2024 (estimated)
- Study completion
- 30 Dec 2024 (estimated)
- First posted
- 18 Jun 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In the early stage, our team found that Acupuncture intervention in freeze-all IVF cycles can improve the clinical pregnancy rate. In order to further study the role of Acupuncture in improving the pregnancy outcome of IVF-ET in infertility. A randomized controlled clinical trial will be used in this study. 90 infertile patients are randomly divided into two groups. The control group will be treated with conventional modern medicine, and the treatment group will be treated with Acupuncture on the basis of conventional modern medicine. The intervention starts from the 5th day of the menstrual cycle and lasts to the day before IVF-ET. The number of oocytes, antral follicles, AMH, serum FSH, and clinical pregnancy rate will be observed to evaluate the effect of Acupuncture on the improvement of pregnancy outcome. In addition, all of the participants will be asked to complete the self-evaluation of the anxiety/depression scale on the 7th day of the menstrual cycle, before and after transplantation, to analyze the emotional changes of the subjects during the study. We observe the safety and health economic indicators of Acupuncture treatment, so as to improve the overall efficacy of TCM Combined Application in assisted reproductive technology in the future.
Detailed description
The study will be conducted on patients with DOR attending our reproductive medicine center for proposed IVF-ET between June 2021and December 2022.
The trial is designed as a randomized, controlled clinical trial with two groups established by 1:1 equal allocation, a treatment group with interventions using acupuncture to tonify the kidneys and regulate blood and a control group treated using conventional Western medicine.
Random numbers will be prepared by an independent third-party statistician who prepared a list of random group codes for this study. Enrolled subjects will be given a subject number during the screening process and, upon formal enrolment, will be randomly assigned to either the test or control group with a corresponding random number.
The acupoints used will be:
Zhongwan (RN12) ：The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Qihai(RN6): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Guanyuan(RN4): The needle should be punctured for 0.8-1.2 inches and retained for 30 minutes.
Zhongji(RN3): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes.
Guilai(ST29): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes.
Shenshu(BL23): The needle should be punctured for 0.8-1.0 inches and retained for 30 minutes.
Ciliao(BL28): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Xuehai(SP10): The needle should be punctured for 1-1.5 inches and retained for 30 minutes.
Zusanli(ST36): The needle should be punctured for 1-1.5 inches and retained for 30 minutes.
Diji(SP8): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Sanyinjiao(SP6): The needle should be punctured for 1-1.2 inches and retained for 30 minutes.
Taixi(KI6): The needle should be punctured for 0.8-1.2 inches and retained for 30 minutes.
Baihui(DU20): The needle should be punctured for 0.5-1.0 inches and retained for 30 minutes.
Yintang(EX-HN3): The needle should be punctured for 0.5-1.0 inches and retained for 30 minutes.
The Acupuncture intervention will start on the 5th day of the menstruation cycle, which will be carried out 1 time per day,at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention.
Serum human chorionic gonadotropin (hCG) will be measured, and an hCG>30 IU will be considered to indicate biochemical pregnancy. Ultrasound monitoring will be performed 30 days after ET to calculate the clinical pregnancy rate.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Acupuncture treatment group | Experimental | Other: AcupunctureMethod: Acupuncture at Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi. The acupuncture treatment starts on the 5th day of the menstrual cycle and lasts to the days before IVF-ET |
| Western medicine group | Active comparator | Other: Western medicineThe western medicine group will be treated with conventional western medicine |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Meet the diagnostic criteria for infertility.
- Meet the criteria for identifying kidney deficiency in TCM.
- Patients who Planning to undergo IVF-ET for pregnancy in our center, Age ≤40 years and ≥25 years.
- Previous embryo transfer failure ≥ 2 times.
- Menstrual cycle is basically normal, and normal ovulation has been monitored in the past.
Key exclusion criteria (8 listed)
- Patients with endometritis, acute pelvic inflammatory disease, mycotic vaginitis, bacterial vaginitis, adnexitis or other systemic infections.
- It has been confirmed that there are obvious and serious other organic lesions in the reproductive organs.
- Patients with allergic constitution
- Infertility caused by genetic factors
- Patients with serious primary diseases such as cardio cerebrovascular, kidney, liver and hematopoietic system and psychosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AcupunctureAlso: conventional western medicine(Recombinant Human Follitropin Alfa for Injection、Fructose Injection、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder for Injection )The Acupuncture intervention（Zhongwan、Qihai、Guanyuan、Zhongji、Guilai、Shenshu、Ciliao、Xuehai、Sanyinjiao、Taixi.） will start on the 5th day of menstruation cycle, which will be carried out 1 time per day, at least 5 times a week, lasts for 10-15days. All operations were performed by experienced acupuncturists. After ET, both the control group and the treatment group will be treated with conventionally with no TCM intervention. | Other | Acupuncture treatment group |
| Western medicineWestern medicine | Other | Western medicine group |
Primary outcome
Clinical pregnancy rate (%)
Time frame: up to 6 weeks from enrollment
Follow up by telephone calls 14days after the IVF-ET
1 secondary outcome
Concentration of β-human Choriogonadotropin(β-HCG)
Time frame: up to 6 weeks from enrollment
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 May 2023.
Related trials for Acupuncture
Recruiting
Clinical Trial for Acupuncture in Adolescents With Psychological Distress and Insomnia
Psychological Distress, Insomnia
Active, not recruiting
The Acupuncture Treatment Effect in Patients With Schizophrenia
Mental Health
Active, not recruiting
AKU Study - Acupuncture for Aromatase Inhibitor-Induced Musculoskeletal Syndrome
Aromatase Inhibitor-Associated Musculoskeletal Syndrome, Arthralgia Syndrome
Recruiting
Acupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy
Diabetic Cardiovascular Autonomic Neuropathy, Type 2 Diabetes Mellitus
Not yet recruiting
Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State
IBS, Constipation Predominant, Anxiety State
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Acupuncture and Western medicine in people with Acupuncture and Female Infertility, run by Peking University Third Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact xiyan xin, associate chief physician (+86 01082264623, frw9606@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical pregnancy rate (%) (time frame: up to 6 weeks from enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2023.